Skip to content

Clinical trials

Phase 1/2 Rare Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Phase 1/2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20161
20181
20191
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Active, not recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
Gemma Biotherapeutics2
Amgen1
Aspa Therapeutics1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Fred Hutchinson Cancer Center1
Hoffmann-La Roche1
Italfarmaco1
Klus Pharma Inc.1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases20
Communicable Diseases3
Genetic Diseases, Inborn3
Hematologic Diseases3
Immune System Diseases3
Lysosomal Storage Diseases3
Metabolic Diseases3
Anemia, Sickle Cell2
Herpesviridae Infections2
Metabolism, Inborn Errors2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.